Ruby Alonso
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 2
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Olivier J Lantz (4 shared papers)Enrique Montero (5 shared papers)Virginie Prémel (3 shared papers)Laurie Menger (2 shared papers)Marion Salou (2 shared papers)Aurélie Darbois (2 shared papers)Yves Renaudineau (5 shared papers)Pierre Youinou (4 shared papers)
In The Last Decade
Ruby Alonso
19 papers receiving 757 citations
Peers
Comparison fields: 5 of 58
- Immunology 361
- Oncology 180
- Rheumatology 38
- Aquatic Science 17
- Radiology, Nuclear Medicine and Imaging 52
Countries citing papers authored by Ruby Alonso
This map shows the geographic impact of Ruby Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Alonso more than expected).
Fields of papers citing papers by Ruby Alonso
This network shows the impact of papers produced by Ruby Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Alonso. The network helps show where Ruby Alonso may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Alonso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 162 | |
| 2 | 2023 | 94 | |
| 3 | 2018 | 83 | |
| 4 | 2003 | 82 | |
| 5 | 2010 | 58 | |
| 6 | 2010 | 48 | |
| 7 | 2007 | 45 | |
| 8 | 2010 | 30 | |
| 9 | 2008 | 29 | |
| 10 | 2009 | 29 | |
| 11 | 2009 | 23 | |
| 12 | 2024 | 22 | |
| 13 | 2013 | 21 | |
| 14 | 2019 | 21 | |
| 15 | 2008 | 15 | |
| 16 | 2015 | 8 | |
| 17 | 2009 | 3 | |
| 18 | Autoreactive B cells and epigenetics. | 2010 | 3 |
| 19 | 2010 | 1 | |
| 20 | Expresión fenotípica de las moléculas CD5 y CD6 en la leucemia linfoide crónica B-CD5+ | 2009 | 0 |
About Ruby Alonso
Ruby Alonso is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 21 papers that have together received 777 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Salivary Gland Disorders and Functions (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunotherapy and Immune Responses (2 papers), Mosquito-borne diseases and control (2 papers), Multiple Sclerosis Research Studies (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Immunology (361 citations), Oncology (180 citations), Rheumatology (38 citations), Aquatic Science (17 citations) and Radiology, Nuclear Medicine and Imaging (52 citations). Ruby Alonso has collaborated with scholars based in Cuba and France. Frequent co-authors include Olivier J Lantz, Enrique Montero, Virginie Prémel, Laurie Menger, Marion Salou, Aurélie Darbois, Yves Renaudineau, Pierre Youinou, Emanuele Procopio and Francois P. Legoux. Their work appears in journals such as The Journal of Experimental Medicine, International Immunopharmacology, Nature Communications, Science Advances and Clinical Reviews in Allergy & Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.